By early 2026, FDA had publicly announced enforcement actions against multiple compounded GLP-1 telehealth platforms, and in April 2026 formally proposed removing semaglutide, tirzepatide, and liraglutide from the 503B outsourcing bulks list - with a public comment period running through June 2026
For many people, however, the condition is chronic
8.1 Challenges in the optimization of multi-receptor agonists Although multi-receptor agonists such as tirzepatide exhibit enhanced effectiveness, their development poses distinct obstacles that need careful attention
Liberty Slim | Science-Backed Therapeutics for Optimal Health
Its always clean and everyone Ive been in contact with is super friendly Augustina L.
"If you don't know what you're taking, you should probably avoid it," Prof Tony Cass says